Product Information
DROXIDOPA 100 MG CAPSULE is a generic product labeled by ScieGen Pharmaceuticals Inc., priced at $0.4456 per EA under NDC 50228042990. Its NADAC has been published 166 times since Jun 21, 2023.
FDA first approved this application on Feb 18, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
ScieGen Pharmaceuticals Inc.NDC
50228042990
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DROXIDOPAApproval Type
Generic (ANDA)
FDA Application
ANDA214017FDA Approved
2/18/2021
TE Code
AB
On Market Since
2/18/2021
Pharmacological Classes
Price Statistics
The NADAC for DROXIDOPA 100 MG CAPSULE has been published 166 times since Jun 21, 2023, and over the history we have for it it has declined 55.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4456 per EA |
|---|---|
| All-time high | $1.0016 (Mar 13, 2024) |
| All-time low | $0.4335 (Jul 22, 2026) |
| 52-week high | $0.9268 |
| 52-week low | $0.4335 |
| Median price | $0.8404 |
| Average price | $0.8123 |
| Largest weekly change | +58.6% (Apr 17, 2024) |
| Weeks tracked | 166 |
| Tracking since | Jun 21, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DROXIDOPA 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DROXIDOPA 100 MG CAPSULE, manufactured by ScieGen Pharmaceuticals Inc., is $0.4456 per EA (NDC 50228042990), effective Aug 19, 2026.
How has the price of DROXIDOPA 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DROXIDOPA 100 MG CAPSULE has declined 55.5%. It has been tracked across 166 weekly CMS publications since Jun 21, 2023.
What are the highest and lowest recorded NADAC prices for DROXIDOPA 100 MG CAPSULE?
Since Jun 21, 2023, the NADAC for DROXIDOPA 100 MG CAPSULE has ranged from a low of $0.4335 (Jul 22, 2026) to a high of $1.0016 (Mar 13, 2024), with a median of $0.8404 per EA.
Are there cheaper alternatives to DROXIDOPA 100 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DROXIDOPA 100 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures DROXIDOPA 100 MG CAPSULE?
DROXIDOPA 100 MG CAPSULE (NDC 50228042990) is labeled by ScieGen Pharmaceuticals Inc., and CMS classifies it as a generic product.